0001388658-20-000258.txt : 20201008 0001388658-20-000258.hdr.sgml : 20201008 20201008155930 ACCESSION NUMBER: 0001388658-20-000258 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201006 FILED AS OF DATE: 20201008 DATE AS OF CHANGE: 20201008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King Kevin M CENTRAL INDEX KEY: 0001385014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37918 FILM NUMBER: 201231017 MAIL ADDRESS: STREET 1: C/O AFFYMETRIX, INC. STREET 2: 3420 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iRhythm Technologies, Inc. CENTRAL INDEX KEY: 0001388658 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208149544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 BUSINESS PHONE: 415-632-5700 MAIL ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies, Inc. DATE OF NAME CHANGE: 20110429 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies Inc DATE OF NAME CHANGE: 20070201 4 1 wf-form4_160218715608724.xml FORM 4 X0306 4 2020-10-06 0 0001388658 iRhythm Technologies, Inc. IRTC 0001385014 King Kevin M C/O IRHYTHM TECHNOLOGIES, INC. 699 8TH ST # 600 SAN FRANCISCO CA 94103 0 1 0 0 President and CEO Common Stock 2020-10-06 4 M 0 5882 17 A 235652 D Common Stock 2020-10-06 4 M 0 6449 8.18 A 242101 D Employee Stock Option (right to buy) 17.0 2020-10-06 4 M 0 5882 0 D 2017-09-21 2026-10-19 Common Stock 5882.0 17918 D Employee Stock Option (right to buy) 8.18 2020-10-06 4 M 0 6449 0 D 2019-12-15 2025-12-15 Common Stock 6449.0 1959 D The option, originally granted for 81,595 shares, of which 63,677 shares have been exercised, vested as to 1/4 of the shares on September 21, 2017 and as to 1/36 of the remaining shares each month thereafter. All of the shares subject to this option are fully vested and exercisable as of the date hereof. Christina Delfin, attorney in fact 2020-10-08